Medtronic announced U.S. FDA approval of its MiniMed 780G system with the Guardian 4 sensor requiring no fingersticks while in SmartGuard technology. This milestone marks the approval of the only system with meal detection technology that provides automatic adjustments and corrections to sugar levels every 5 minutes for both basal and bolus insulin needs. The system provides insulin to help account for when users occasionally forget to bolus or underestimates the number of carbs in their meal.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MDT:
- Tandem Diabetes down 5% after FDA approves Medtronic’s MiniMed 780G
- Medtronic up 3% after FDA approves expanded indication for MiniMed 780G System
- FDA approves Medtronic MiniMed 780G System for modifications
- Piper wonders if Medtronic’s 780G will be delayed further by FDA inspections
- Medtronic price target lowered to $88 from $90 at Truist